Has Juan Perez, DO received payments from drug or device companies?

Yes. Drug and device makers reported $688 in general payments to Juan Perez, DO across 16 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Juan Perez, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Juan Perez, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Juan Perez, DO

Family Medicine · Reading, PANPI 1659359180

Payments from drug & device makers

$688in general payments, 2019–2025

Across 16 payments — averaging $42.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$139
AstraZeneca$124
Otsuka America Pharmaceutical, Inc.$110
Phathom Pharmaceuticals, Inc.$110
Alkermes, Inc.$110
Sanofi-aventis U.S. LLC$45
plus $50 from 2 others

What the payments were for

Food & beverage$64894%
Education$406%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	2	$139
AstraZeneca	1	$124
Otsuka America Pharmaceutical, Inc.	1	$110
Phathom Pharmaceuticals, Inc.	1	$110
Alkermes, Inc.	5	$110
Sanofi-aventis U.S. LLC	3	$45
Lilly USA, LLC	2	$37
Novo Nordisk	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$688 in reported general payments places this provider in the 60th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$27,045

Medicare patients

158

Services billed

313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	28	$34,791
TrulicityDulaglutide	31	$29,394
JanumetSitagliptin Phos/Metformin Hcl	23	$26,734
JanuviaSitagliptin Phosphate	30	$20,584
EliquisApixaban	17	$10,637
Advair HfaFluticasone Propion/Salmeterol	25	$7,803
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	57	$5,768
DuleraMometasone/Formoterol	12	$4,116
True Comfort Safety Pen NeedlePen Needle, Diabetic, Safety	12	$3,528
VascepaIcosapent Ethyl	11	$2,647
Icosapent Ethyl	12	$2,373
Insulin Lispro Kwikpen U-100Insulin Lispro	14	$2,211
Gabapentin	166	$1,847
Alcohol Prep PadsAlcohol Antiseptic Pads	16	$1,693
Albuterol Sulfate HfaAlbuterol Sulfate	70	$1,610

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Lilly USA, LLCTrulicity	$37	$29,39431 claims
PfizerEliquis	$139	$10,63717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,967 family medicine providers in Pennsylvania.